| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f38dbf49a861c082228ee1c88b694814
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9fc46919693cd42687f209adf860d548
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d9be523639659ce625f685c5d7c092c2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a06fa340ef3e5db182c48a6889cd2aa5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_be404842fe6344f96a01f6a70cf85162
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_32107452ab21347d2c0203d8cfb068eb |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4703 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 |
| filingDate |
2007-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df60e07608d82fa2d010c2aaddf3cbe6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_430fc65a1ecdfdf5e45bb4c2a41e8779
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a44ea3cde1cc4b1babf401b149bad64b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20e5dbd16d0029bace004a50811b67cd |
| publicationDate |
2008-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2008034162-A1 |
| titleOfInvention |
Compositions and uses thereof in the treatment of wounds |
| abstract |
The present invention provides a topical composition comprising (i) an amount of an AP-1 signaling inhibitor sufficient to reduce, delay or prevent apoptosis and/or necrosis induced by dermal wounding and/or to induce and/or enhance proliferation of a cell; and (ii) a suitable carrier or excipient e.g., a topical carrier or excipient or other carrier or excipient for dermal application. For example, the AP-1 signaling inhibitor is a peptide analog comprising the sequence set forth in SEQ ID NO: 104. The present invention also provides a method of treating a dermal wound comprising topically administering said topical composition to a subject suffering from a dermal wound. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8946381-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2074138-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2170932-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2170932-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8063012-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8822409-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2074138-A1 |
| priorityDate |
2006-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |